Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Robert Croop

3PUBLICATIONS

9CO-AUTHORS

Air pollution modelling and controlPharmacogenomicsWastewater treatment processes

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (3)

Sort by Publication Date:

|Nov 27, 2024

Deconvoluting zavegepant drug-drug interactions: A phase I study to evaluate the effects of rifampin and itraconazole on zavegepant pharmacokinetics.

Rajinder Bhardwaj, Jo Ann Malatesta, Jennifer Madonia

|Sep 30, 2024

Mass balance and pharmacokinetic characterization of zavegepant in healthy male subjects.

Rajinder Bhardwaj, Mary Donohue, Jennifer Madonia

|Jul 17, 2024

Reduced hepatic impairment study to evaluate pharmacokinetics and safety of zavegepant and to inform dosing recommendation for hepatic impairment.

Rajinder Bhardwaj, Mary K Donohue, Jennifer Madonia

Pageof 1

Frequent Collaborators

3 joint publications

Rajinder Bhardwaj

3 joint publications

Jennifer Madonia

3 joint publications

Kyle T Matschke

3 joint publications

Richard Bertz

3 joint publications

Jing Liu

2 joint publications

Mary K Donohue

2 joint publications

Beth Morris

2 joint publications

Matt S Anderson

1 joint publications

Thomas C Marbury

Frequent Collaborators

3 joint publications

Rajinder Bhardwaj

3 joint publications

Jennifer Madonia

3 joint publications

Kyle T Matschke

3 joint publications

Richard Bertz

Top Related Videos

Optimized LC-MS/MS Method for the High-throughput Analysis of Clinical Samples of Ivacaftor, Its Major Metabolites, and Lumacaftor in Biological Fluids of Cystic Fibrosis Patients

Optimized LC-MS/MS Method for the High-throughput Analysis of Clinical Samples of Ivacaftor, Its Major Metabolites, and Lumacaftor in Biological Fluids of Cystic Fibrosis Patients

Published on : Oct 15, 2017

An Intestine/Liver Microphysiological System for Drug Pharmacokinetic and Toxicological Assessment

An Intestine/Liver Microphysiological System for Drug Pharmacokinetic and Toxicological Assessment

Published on : Dec 03, 2020

See more related videos

Top Related Videos

Optimized LC-MS/MS Method for the High-throughput Analysis of Clinical Samples of Ivacaftor, Its Major Metabolites, and Lumacaftor in Biological Fluids of Cystic Fibrosis Patients

Optimized LC-MS/MS Method for the High-throughput Analysis of Clinical Samples of Ivacaftor, Its Major Metabolites, and Lumacaftor in Biological Fluids of Cystic Fibrosis Patients

Published on : Oct 15, 2017

An Intestine/Liver Microphysiological System for Drug Pharmacokinetic and Toxicological Assessment

An Intestine/Liver Microphysiological System for Drug Pharmacokinetic and Toxicological Assessment

Published on : Dec 03, 2020

See more related videos